Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pardes Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pardes Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tananbaum James B. | President and CEO | 1,000Indirect | Aug 31, 2023 | 0 |
| Foresite Capital Fund V, L.P. | 10% Owner | 1,000Indirect | Aug 31, 2023 | 0 |
| Foresite Capital Opportunity Fund V, L.P. | 10% Owner | 1,000Indirect | Aug 31, 2023 | 0 |
| Foresite Capital Management V, LLC | 10% Owner | 1,000Indirect | Aug 31, 2023 | 0 |
| Foresite Capital Opportunity Management V, LLC | 10% Owner | 1,000Indirect | Aug 31, 2023 | 0 |
| FS Development Holdings II, LLC | 10% Owner | 1,000Indirect | Aug 31, 2023 | 0 |
| Auerbach Mark | Director | 0 | Aug 31, 2023 | 0 |
| Lobell J Jay | Director | 0Indirect | Aug 31, 2023 | 0 |
| Wiggans Thomas G | Chief Executive Officer | 0 | Aug 31, 2023 | 0 |
| Henson Heidi | Chief Financial Officer | 0 | Aug 31, 2023 | 0 |
| Pottage John C Jr | Director | – | Aug 31, 2023 | 0 |
| Smaldone Alsup Laurie | Director | – | Aug 31, 2023 | 0 |
| Lopatin Uri A | Director | 0Indirect | Aug 31, 2023 | 0 |
| Varney Michael David | Director | 0 | Aug 31, 2023 | 0 |
| Hamill Laura | Director | – | Aug 31, 2023 | 0 |
| Autor Deborah M. | Director | – | Aug 31, 2023 | 0 |
| Lacy Elizabeth H. | General Counsel, Secretary | 0 | Aug 31, 2023 | 0 |
| Brusky Sean P. | Chief Commercial Officer | 21,000 | Feb 3, 2023 | 0 |
| Kearney Brian | Chief Development Officer | – | Feb 3, 2023 | 0 |
| Tinmouth Brian Philippe | Chief Bus. & Strategy Officer | – | Sep 16, 2022 | 0 |
| Arnold Lee D | Chief Scientific Officer | – | Feb 2, 2022 | 0 |
| Pakianathan Deepika | Director | 30,000 | Dec 30, 2021 | 0 |
| Hughes Owen | Director | 30,000 | Dec 30, 2021 | 0 |
| Dubin Daniel | Director | 30,000 | Dec 30, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 (view filing)9:08 PM ET | Apr 5 | 1 day | Tananbaum James B. and 2 othersDirector, 10% Owner | PPurchase | +774.0K | $1.50 | +$1.16M | +9.7%8.77M after | |
| Apr 6, 2023 (view filing)9:08 PM ET | Apr 5 | 1 day | Tananbaum James B. and 2 othersDirector, 10% Owner | PPurchase | +774.0K | $1.50 | +$1.16M | +6.0%13.6M after | |
| Dec 12, 2022 (view filing) | Dec 8 | 4 days | Brusky Sean P.Chief Commercial Officer | PPurchase | +21.0K | $1.19 | +$25.0K | New position21.0K after | |
| Dec 7, 2022 (view filing) | Dec 5 | 2 days | Wiggans Thomas GChief Executive Officer | PPurchase | +12.5K | $1.09 | +$13.6K | +33.3%50.0K after | |
| Dec 5, 2022 (view filing)4:24 PM ET | Dec 1 | 4 days | Tananbaum James B. and 2 othersDirector, 10% Owner | PPurchase | +637.4K | $0.85 | +$541.8K | +5.2%12.8M after | |
| Dec 5, 2022 (view filing) | Dec 1-2 | 4 days | Wiggans Thomas GChief Executive Officer | PPurchase | +37.5K | $1.05 | +$39.4K | New position37.5K after | 2 lots |
| Dec 23, 2021 (view filing)4:52 PM ET | Dec 22 | 1 day | Tananbaum James B. and 4 othersDirector, 10% Owner | PPurchase | +325.0K | $10.00 | +$3.25M | New position325.0K after |